Tieni traccia delle ultime attività di insider trading Summit Therapeutics. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Summit Therapeutics.
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
A Summit Therapeutics Inc, la recente attività interna ha attirato l'attenzione. Negli ultimi 30 giorni, gli addetti ai lavori non hanno segnalato vendite negli ultimi 30 giorni, mentre gli addetti ai lavori hanno segnalato di aver acquistato un totale di 676.79K azioni per un valore totale di $11.97M.
Sep 11, 2025 | CO-CHIEF EXECUTIVE OFFICER | 338.39K | $17.69 | $5.98M | BUY | 0.06% | 556.12M | Sep 10 - Sep 11 | ||
Sep 11, 2025 | CO-CHIEF EXECUTIVE OFFICER | 338.39K | $17.69 | $5.98M | BUY | 0.06% | 556.14M | Sep 10 - Sep 11 | ||
Mar 27, 2024 | CHIEF EXECUTIVE OFFICER | 110.32K | $3.73 | $411.09K | BUY | ∞ | 50.00K | Mar 26 - Mar 27 | ||
Mar 27, 2024 | CHIEF FINANCIAL OFFICER | 100.00K | $3.75 | $375.00K | BUY | 39.22% | 354.96K | Mar 26 | ||
Dec 13, 2023 | CHIEF EXECUTIVE OFFICER | 810.50K | $1.50 | $1.21M | BUY | 3.37% | 24.89M | Dec 11 - Dec 12 | ||
Dec 13, 2023 | CHIEF FINANCIAL OFFICER | 20.40K | $2.17 | $44.25K | BUY | 8.70% | 254.96K | Dec 13 | ||
Oct 16, 2023 | CHIEF OPERATING OFFICER | 2.98M | $1.68 | $5.00M | BUY | ∞ | 2.98M | Oct 13 | ||
Mar 08, 2023 | CO-CHIEF EXECUTIVE OFFICER | 23.53M | $1.05 | $24.70M | BUY | ∞ | 9.88M | Mar 08 | ||
Mar 08, 2023 | CHIEF FINANCIAL OFFICER | 196.36K | $1.05 | $206.18K | BUY | 252.64% | 274.08K | Mar 07 | ||
Mar 08, 2023 | CHIEF EXECUTIVE OFFICER | 376.49M | $1.05 | $395.31M | BUY | 214.08% | 552.35M | Mar 06 | ||
Aug 18, 2022 | CHIEF EXECUTIVE OFFICER | 94.85M | $0.97 | $92.00M | BUY | 140.14% | 162.53M | Aug 16 | ||
Aug 18, 2022 | CO-CEO & PRESIDENT | 5.81M | $0.97 | $5.63M | BUY | ∞ | 3.14M | Aug 16 | ||
Aug 17, 2022 | CHIEF FINANCIAL OFFICER | 36.22K | $0.97 | $35.13K | BUY | 1828.12% | 38.20K | Aug 16 | ||
May 14, 2021 | CHIEF EXECUTIVE OFFICER | 11.37M | $5.24 | $59.56M | BUY | 20.19% | 67.66M | May 12 | ||
May 14, 2021 | CHIEF OPERATING OFFICER | 389.08K | $5.24 | $2.04M | BUY | 8.93% | 4.75M | May 12 | ||
Dec 01, 2020 | — | 0.00 | $3.12 | -$111.06K | OPTION EXERCISE | 0.00% | 0.00 | Nov 27 - Nov 30 | ||
Nov 25, 2020 | — | 0.00 | $3.11 | -$72.34K | OPTION EXERCISE | 0.00% | 0.00 | Nov 23 - Nov 25 | ||
Nov 10, 2020 | — | 14.07M | $3.34 | $47.00M | PURCHASE | 33.33% | 56.30M | Nov 06 |
Sfoglia insider trading su tutte le azioni.